General Information of Drug (ID: DM1TH08)

Drug Name
Ferricyanide Drug Info
Synonyms
Ferric hexacyanide; Ferricyanide; Hexacyanoferrate(III); Hexazyanoferrat(III); hexacyanidoferrate(3-); hexacyanidoferrate(III); hexacyanoferrate III; hexacyanoferrate(3-); hexacyanoiron(3-); 13408-62-3; CHEBI:5020; CRWNKXHVYMVLCY-UHFFFAOYSA-N; [Fe(CN)6](3-)
Cross-matching ID
PubChem CID
439210
ChEBI ID
CHEBI:5020
CAS Number
CAS 13408-62-3
TTD Drug ID
DM1TH08
INTEDE Drug ID
DR2046

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DME
Drug Status:
Approved Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [1]
Folic Acid DMEMBJC Colorectal carcinoma Approved [3]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [1]
Dichloroindophenol DMAEI51 N. A. N. A. Investigative [1]
Drug(s) Metabolized By Diaphorase-1 (CYB5R3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
NADH DM5NM6E Parkinson disease 8A00.0 Approved [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Methionine synthase reductase (MTRR) DE6NIY9 MTRR_HUMAN Substrate [1]
Diaphorase-1 (CYB5R3) DE4A3BL NB5R3_HUMAN Substrate [2]

References

1 Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry. 2002 Nov 12;41(45):13378-85.
2 Expression of a novel P275L variant of NADH:cytochrome b5 reductase gives functional insight into the conserved motif important for pyridine nucleotide binding. Arch Biochem Biophys. 2006 Mar 1;447(1):59-67.
3 Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome in China. J Zhejiang Univ Sci B. 2008 Feb;9(2):93-9.